Long-Term Safety of Rituximab in DLBCL Patients With Hepatitis B-Related Cirrhosis: A Retrospective Case Series

OBJECTIVE: Chemotherapy regimens containing rituximab (RTX) have been extensively used to treat diffuse large B cell lymphoma (DLBCL). However, data looking at long-term safety of DLBCL patients with hepatitis B-related cirrhosis are still lacking. This study aims to report the safety and outcomes o...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Zaiwei, Ma, Yi, Jiang, Dan, Zhao, Rongsheng, Dong, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9195509/
https://www.ncbi.nlm.nih.gov/pubmed/35712098
http://dx.doi.org/10.3389/fmed.2022.890339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9195509/
https://www.ncbi.nlm.nih.gov/pubmed/35712098
http://dx.doi.org/10.3389/fmed.2022.890339

Ejemplares similares